ParoScan 3Di vs Xtremity 3D by PAL Uso & Estadísticas

FOCUS ON QUALITY AND QUALITY The paroScan 3D is the cost-effective alternative to plantar scanning of feet and scanning of foam impressions using a 3D scanner. With the paroScan 3D, users without high coverage numbers can use modern 3D technology. Because in conjunction with an iPad, this scanner becomes an affordable and mobile 3D scanning unit. CONVINCING IN PRICE AND PERFORMANCE The paroScan 3D is a powerful device for modern, mobile foot care: Easy installation and handling Innovative technology Suitable app for innovative work PROGRAMMED FOR COST-EFFICIENCY The powerful paromed app enables users to work cost-effectively and time-saving: scans can be displayed on the iPad and made available for direct import into the paroManager. And that in the right paromed format, as the 3D scanner fits seamlessly into the paroContour software and no post-processing is necessary. COMPATIBLE iPads Please double check what iPads can be used with the Structure Sensor scanner before downloading the app. Terms of Use: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
  • App Store de Apple
  • Gratis
  • Medicina

Clasificación de tiendas

- -

PAL Health Technologies 3D scanning application for ordering orthotics. The easy way to scan and place orders for custom orthotics from PAL Health Technologies. Fast, clean, and user friendly application.
  • App Store de Apple
  • Gratis
  • Medicina

Clasificación de tiendas

- -

ParoScan 3Di frente a Xtremity 3D by PAL: comparación de la clasificación

Comparar la tendencia de clasificación de ParoScan 3Di en los últimos 28 días con Xtremity 3D by PAL

Rank

No hay datos disponibles

Comparación de las clasificaciones ParoScan 3Di frente a Xtremity 3D by PAL por países

Comparar la tendencia de clasificación de ParoScan 3Di en los últimos 28 días con Xtremity 3D by PAL

No hay datos para mostrar

Compara con cualquier sitio gracias a nuestra prueba gratuita

Empieza ya
ParoScan 3Di VS.
Xtremity 3D by PAL

13iciembre d, 2024